Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Natalizumab |
Trade Name | Tysabri |
Synonyms | Anti-VLA4 |
Drug Descriptions |
Tysabri (natalizumab) is a monoclonal antibody that binds to alpha 4 integrin and inhibits adhesion, resulting in immune modulation and anti-tumor activities (PMID: 23319569). |
DrugClasses | |
CAS Registry Number | 189261-10-7 |
NCIT ID | C77862 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Natalizumab | Natalizumab | 0 | 1 |